Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sista versen 92300 AB
AB
Dissolved
Org 5593859530
Lund
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Sista versen 92300 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
50
15
Staff expenses
—
—
EBITDA
−30
−16
Depreciation & amort.
—
—
EBIT
−30
−16
Net financials
0
0
Profit before tax
−30
−16
Tax
—
—
Net profit
−30
−16
Balance sheet
SEK thousands
Item
2023
2024
Total assets
15
19
Equity
−5
−21
Long-term debt
—
—
Short-term debt
19
40
Total debt
19
40
Financial ratios
5-year trend
EBITDA margin
-106.9%
This company
15.8%
Market median
-777% vs market
2023
2024
Equity ratio
-107.6%
This company
38.2%
Market median
-382% vs market
2023
2024
Return on equity
-1590500.0%
This company
18.4%
Market median
-8644122% vs market
2023
2024
Net profit margin
-106.0%
This company
8.1%
Market median
-1409% vs market
2023
2024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
2023
2024
Debt / equity
1.93×
This company
0.62×
Market median
-211% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-06-21 – 2023-08-31
View
PDF
More on Sista versen 92300 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network